Radiotracer Development
Radiotracer Development is a multidisciplinary subfield of nuclear medicine and theranostics that focuses on the design, radiolabeling, optimization, and systematic preclinical and clinical validation of radiopharmaceutical probes so that they selectively interrogate or treat defined biological targets while exhibiting suitable pharmacokinetics, safety, and imaging or therapeutic performance.
2.2K
Publications
92.8K
Citations
9K
Authors
1.7K
Institutions
Publications per year
2017–2026
585
2.2K
Jean Claude Reubi, Jean-Claude Schär, Beatrice Waser et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2000 · 1.1K citations
Frederik L. Giesel, Clemens Kratochwil, Thomas Lindner et al. · Journal of Nuclear Medicine · 2018 · 722 citations · Full text
Medicine, Nuclear Medicine, Oncology +17
Chemistry with [<sup>18</sup>F]Fluoride Ion
Lisheng Cai, Shuiyu Lu, Victor W. Pike · European Journal of Organic Chemistry · 2008 · 466 citations
1–5 of 2.2K
9K
28
h-index
26
h-index
23
h-index
22
h-index
21
h-index
1–5 of 9K
1.7K
National Institutes of Health
Bethesda, United States
30 h-index
368 publications
15.9K citations
Harvard University
Cambridge, United States
27 h-index
242 publications
9.1K citations

Karolinska Institutet
Stockholm, Sweden
27 h-index
266 publications
8.5K citations
Inserm
Paris, France
26 h-index
270 publications
9.1K citations
Hammersmith Hospital
London, United Kingdom
26 h-index
173 publications
6.3K citations
Massachusetts General Hospital
Boston, United States
26 h-index
226 publications
8.5K citations
Mallinckrodt (United States)
Hazelwood, United States
26 h-index
130 publications
7.2K citations
National Institute of Mental Health
Bethesda, United States
26 h-index
274 publications
12.5K citations
1–8 of 1.7K
Repository · 152 publications · 10.4K citations
55
h-index
147 publications · 6.4K citations
47
h-index
101 publications · 8.4K citations
47
h-index
107 publications · 5.7K citations
46
h-index
NMB · 192 publications · 6.6K citations
42
h-index
1–5